IVD WHO EUL Public Report for SARS-CoV-2: Product: Novel Coronavirus (SARS-CoV-2) Real-Time Multiplex RT-PCR Kit EUL Number: EUL-0486-139-00 Report
IVD WHO EUL Public Report for SARS-CoV-2: Product: RT-PCR Kit for Detecting SARS-CoV-2 (Real-time Fluorescent PCR) EUL Number: EUL 0507-195-00 PDF Report
IVD WHO EUL Public Report for SARS-CoV-2: Product: SARS-CoV-2 Nucleic Acid Detection Kit (Fluorescent RT-RAA) EUL Number: EUL 0512-199-00 PDF Report
IVD WHO EUL Public Report for SARS-CoV-2: Product: STANDARD Q COVID-19 Ag Test EUL Number: EUL 0563-117-00 PDF Report
IVD WHO EUL Public Report for SARS-CoV-2: Product: Sure Status COVID-19 Antigen Card Test EUL Number: EUL-0590-010-00 Information note
IVD WHO EUL Public Report for SARS-CoV-2: Product: TaqPath COVID‑19 CE‑IVD RT‑PCR Kit EUL Number: EUL-0525-156-00 Report
IVD WHO EUL Public Report for SARS-CoV-2: Product:Novel Coronavirus (2019-nCoV) Antibody Rapid Test EUL Number: EUL 0552-219-00 PDF Report
IVD WHO EUL Public Report for SARS-CoV-2: SARS-CoV-2 Antigen Rapid Test (Self-Testing) EUL Number: EUL 0707-021-00 PDF Guideline/guidance
M WHO guideline on Biopharmaceutics Classification System-based biowaiver (2024) - TRS1052, Annex 7 PDF Guideline/guidance
M WHO Guidelines on submission of documentation for the pilot procedure for prequalification of biotherapeutic products for human insulin - full assessment pathway PDF Guideline/guidance
M WHO Guidelines on submission of documentation for the pilot procedure for prequalification of human insulin approved by Stringent regualtory authorities - abridged assessment pathway PDF Guideline/guidance
M WHO Guidelines on submission of documentation for the pilot procedure for prequalification of rituximab or trastuzumab approved by stringent regulatory authorities - Abridged Assessment PDF Guideline/guidance
M WHO Guidelines on submission of documentation for the pilot procedure for prequalification of similar biotherapeutic products for rituximab and trastuzumab. Preparation of product dossiers in common technical document format - Full Assessment PDF Guideline/guidance
M WHO Guidelines on submission of documentation for the procedure for prequalification of biotherapeutic products or their corresponding similar biotherapeutic products approved by stringent regulatory authorities PDF Guideline/guidance
M WHO Guidelines on submission of documentation for the procedure for prequalification of similar biotherapeutic products PDF Guideline/guidance
ID WHO Immunization Devices Guidelines for applicants & prequalification holders v2.2 PDF Guideline/guidance
ID WHO Immunization Devices Pocket Guide for applicants & prequalification holders v2.2 PDF Guideline/guidance
V WHO Operational Tool for efficient and effective lot release of SARS-CoV-2 (Covid-19) vaccines PDF Guideline/guidance
V WHO Package Leaflet - BioNtech Tozinameran – COVID-19 mRNA vaccine (nucleoside modified) - Grey Cap PDF Guideline/guidance
V WHO Package Leaflet - BioNtech Tozinameran – COVID-19 mRNA vaccine (nucleoside modified) - Orange Cap PDF Guideline/guidance
V WHO Package Leaflet - BioNtech Tozinameran – COVID-19 mRNA vaccine (nucleoside modified) - Purple Cap PDF Guideline/guidance
M WHO Pilot Procedure for Prequalification of Biotherapeutic Products: Human Insulin PDF Guideline/guidance
M WHO Pilot Procedure for Prequalification of Biotherapeutic Products: rituximab and trastuzumab PDF Guideline/guidance